切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2020, Vol. 14 ›› Issue (06) : 624 -627. doi: 10.3877/cma.j.issn.1674-3946.2020.06.025

所属专题: 文献

论著

三种手术方式治疗cT1N0期甲状腺癌的近期疗效及安全性比较
李涛1, 焦良和1,(), 朱正才1, 董文武2, 姚天琦1   
  1. 1. 225300 泰州市人民医院普外科
    2. 110001 中国医科大学第一附属医院甲状腺外科
  • 收稿日期:2020-06-09 出版日期:2020-12-26
  • 通信作者: 焦良和

Comparison of the short-term efficacy and the safety of three kinds of surgical procedures for patients with cT1N0 thyroid cancer

Tao Li1, Lianghe Jiao1,(), Zhengcai Zhu1, Wenwu Dong2, Tianqi Yao1   

  1. 1. Department of General Surgery, People's Hospital of Taizhou city, Jiangsu 225300, China
    2. Department of Thyroid Surgery, the First Affiliated Hospital of China Medical University, Liaoning 110001, China
  • Received:2020-06-09 Published:2020-12-26
  • Corresponding author: Lianghe Jiao
  • About author:
    Corresponding author: Jiao LiangHe, Email:
  • Supported by:
    Liaoning Science and Technology Department Project(20141042)
引用本文:

李涛, 焦良和, 朱正才, 董文武, 姚天琦. 三种手术方式治疗cT1N0期甲状腺癌的近期疗效及安全性比较[J/OL]. 中华普外科手术学杂志(电子版), 2020, 14(06): 624-627.

Tao Li, Lianghe Jiao, Zhengcai Zhu, Wenwu Dong, Tianqi Yao. Comparison of the short-term efficacy and the safety of three kinds of surgical procedures for patients with cT1N0 thyroid cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2020, 14(06): 624-627.

目的

对比三种手术方式治疗cT1N0期甲状腺癌的近期疗效及安全性。

方法

回顾性队列研究2017年1月至2019年5月73例cT1N0期甲状腺癌患者资料,根据术式不同分为3组。25例患者纳入开放组,将实施全乳晕入路腔镜手术治疗的24例患者纳入全乳晕组,将经口腔前庭入路腔镜手术治疗的24例患者纳入经口腔组。采用SPSS23.0软件进行处理,围术期相关指标、视觉模拟评估量表(VAS)、Vancouver疤痕评定量表(VSS)评分以(±s)表示,多组间采用单因素方差分析;疗效、并发症用χ2检验,P<0.05为差异有统计学意义。

结果

经口腔组、全乳晕组治疗总有效率(91.7%、87.5%)均比开放组(64.0%)高(P<0.05);经口腔组、全乳晕组手术时间长于开放组(P<0.05),但术中出血量、术后引流量及术后住院时间均比开放组低(P<0.05);经口腔组术后3 d、1个月的VAS评分、VSS评分<全乳晕组<开放组(P<0.05);经口腔组、全乳晕组并发症发生率(8.3%、8.3%)比开放组低(32.0%),差异有统计学意义(P<0.05)。

结论

相比开放手术,腔镜下甲状腺手术治疗cT1N0期甲状腺癌的疗效更佳、并发症更少、住院时间更短,可作为优选治疗方案。

Objective

To compare the short-term efficacy and the safety of three kinds of surgical procedures for patients with cT1N0 stage thyroid cancer.

Methods

A retrospective cohort study was conducted in 73 patients with cT1N0 thyroid cancer from January 2017 to May 2019, who were divided into three groups according to different surgical methods, including 25 patients in the open group, 24 patients in the whole areola group and 24 patients in the transoral group. Statistical analysis were performed by using SPSS 23.0 software. Measurement data, such as perioperative related indicators, visual analogue scale (VAS) and Vancouver Scar Scale (VSS) scores were expressed as (±s), and were examined by using One-way analysis of variance. Short-term efficacy and postoperative complications were analyzed by using χ2 test A P value <0.05 was considered as statistically significant difference.

Results

The total effective rate of 91.7% amd 87.5% in the trans-oral group and total areola group was higher than 64.0% in the open group (P<0.05); while the operation time in the trans-oral group and total areola group was longer than that in the open group (P<0.05) However, in terms of the intraoperative blood loss, postoperative drainage, and postoperative hospital stay were much lower than those in the open group respectively (P<0.05); the VAS score and VSS score at POD3 and 1 month in the oral group were less than those in the total areola group and the open group (P<0.05); The incidence of postoperative complications of 8.33% and 8.33% was much lower in the transoral group and the whole areola group than 32.0% in the open group (P<0.05).

Conclusion

Compared with open surgery, endoscopic thyroid surgery has better curative effect, fewer complications, and shorter hospital stay in the surgical treatment of cT1N0 stage thyroid cancer, and could be used as the preferred therapuetic treatment.

表1 73例cT1N0期甲状腺癌患者不同术式三组一般资料对比[(±s),例]
表2 73例cT1N0期甲状腺癌患者不同术式三组疗效比较[例(%)]
表3 73例cT1N0期甲状腺癌患者不同术式三组围术期相关指标比较(±s)
表4 73例cT1N0期甲状腺癌患者不同术式三组VAS、VSS评分比较[(±s),分]
表5 73例cT1N0期甲状腺癌患者不同术式三组术后并发症比较(例)
[1]
刘媛超,丁汉,王义增,等.甲状腺癌AJCC/TNM分期系统第8版与第7版在分化型甲状腺癌诊治中应用比较[J].中国实用外科杂志,2018, 38(6): 639-642.
[2]
乐飞,游小龙,陈雯,等.小切口腔镜辅助甲状腺切除术治疗分化型甲状腺癌的疗效观察[J].实用癌症杂志,2018, 33(2): 227-229.
[3]
章小华,许年凤.超声引导下穿刺活检在结节性甲状腺肿合并甲状腺癌诊断中的应用价值探究[J].山西医药杂志,2018, 47(9): 1056-1059.
[4]
赵蓓,周军.分化型甲状腺癌手术治疗的中美指南比较及手术原则[J].广西医学,2018, 40(1): 86-88.
[5]
夏旭良.经口入路腔镜下甲状腺癌根治术的临床疗效及预后分析[J/CD].中华普外科手术学杂志(电子版),2020, 14(1): 94-96.
[6]
李小毅,张波,林岩松.成人甲状腺结节与分化型甲状腺癌诊治指南(2015年美国甲状腺协会)解读[J].中华耳鼻咽喉头颈外科杂志,2017, 52(4): 309-315.
[7]
Vaisman F, Tuttle RM.Clinical Assessment and Risk Stratification in Differentiated Thyroid Cancer[J].Endocrinol Metab Clin North Am,2019, 48(1): 99-108.
[8]
Jongekkasit I, Jitpratoom P, Sa sanakietkul T,et al.Transoral Endoscopic Thyroidectomy for Thyroid Cancer[J]. Endocrinol Metab Clin North Am, 2019, 48(1): 165-180.
[9]
黄钰,赵冬夏,李长江.3D及2D腔镜甲状腺全切术治疗分化型甲状腺癌的疗效比较[J].安徽医学,2020, 41(2): 178-180.
[10]
赵明,谭卓,王可敬,等.甲状腺癌改良腋乳入路腔镜手术应用研究[J].中华肿瘤防治杂志,2018, 25(10): 730-733.
[11]
常伟,韩星敏,刘保平,等.老年甲状腺癌患者手术临床疗效和预后分析[J].中华老年医学杂志,2018, 37(10): 1115-1117.
[12]
王宇,沈强,渠宁.分化型甲状腺癌颈侧区淋巴结清扫术中神经损伤的预防[J].中国实用外科杂志,2018, 38(6): 624-628.
[13]
朱见,贺青卿,郑鲁明,等.达芬奇机器人双侧腋窝乳晕入路在甲状腺癌手术中的规范应用[J].临床耳鼻咽喉头颈外科杂志,2018, 32(14): 1071-1074.
[14]
彭瑶,白宁,王文龙,等.全乳晕腔镜途径与传统开放手术治疗T1期乳头状甲状腺癌的疗效比较[J].中国普通外科杂志,2018, 27(5): 535-540.
[15]
Chai YJ, Chung JK, Anuwong A,et al.Transoral endoscopic thyroidectomy for papillary thyroid microcarcinoma: initial experience of a single surgeon[J].Ann Surg Treat Res,2017, 93(2): 70-75.
[16]
项洋锋,郑传铭,葛明华.无充气耳后发际入路完全腔镜下甲状腺癌根治术效果初探[J].中国癌症杂志,2019, 29(6): 434-438.
[17]
林福生,傅锦波,林恩德,等.持续术中神经监测技术在经口腔前庭入路腔镜甲状腺癌根治术中的应用[J].中华普通外科杂志,2019, 34(6): 544-545.
[18]
张大奇,李世杰,付言涛,等.纳米炭在双侧乳晕入路腔镜下甲状腺癌根治术中的应用[J].中华实验外科杂志,2019, 36(8): 1488-1489.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[3] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[4] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[5] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[6] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[7] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[8] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[9] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[10] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[11] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[12] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[13] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[14] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[15] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
阅读次数
全文


摘要